Market Introduction
Biopsy is a medical examination conducted by surgeons or radiologists to evaluate and eliminate cancer tissues. A tissue sample is taken to diagnose the disease, especially when a patient is presumed to have cancer. Different types of biopsies used in cancer diagnosis include skin biopsy, vacuum biopsy, fine needle aspiration, shave biopsy, incision and excision biopsy, needle biopsy, and others.
Market Overview and Dynamics
The Asia Pacificbiopsy devicesmarket is to reach US$ 744.80 Mn by 2027 from US$ 440.80 Mn in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027. Factors such as surging prevalence of cancer, and growing number of government initiatives are expected to boost the growth of the biopsy devices market in the coming years. However, the market is likely to get impacted by the risk factor such as limitations associated to biopsy devices during the forecast period.
Key Market Segments
In terms of product, the needle-based biopsy segment accounted for the largest share of the Asia Pacificbiopsy devicesmarket in 2019. The breast biopsysegment accounted for the largest share of the market, by application, in 2019. In terms of enduser, the ultrasound-guided biopsy segment held the most significant share of the marketin2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Asia Pacificbiopsy devicesmarket report are theWorld Health Organization (WHO), National Center for Biotechnology Information (NCBI),Globocan report, andso on.
Reasons to buy report
- It provides understanding of the Asia Pacific, biopsy devices market landscape and identifies biopsy devicesmarket segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacificbiopsy devices market.
- It helps efficiently plan merger and acquisition, and partnership deals in the biopsy devicesmarket by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis ofbiopsy devicesmarket performance of various segments pertaining to the Asia Pacificbiopsy devices market.
- It providesbiopsy devicesmarket revenue forecast of the market based on various segments for the period from 2019 to 2027.
ASIA PACIFICBIOPSY DEVICESMARKET SEGMENTATION
By Product
-
Needle-Based Biopsy
- Core Biopsy Devices
- Aspiration Biopsy Needles
- Vacuum-Assisted Biopsy (VAB) Devices
- Localization Wires
- Procedure Trays
- Others
By Application
- Lung Biopsy
- Kidney Biopsy
- Liver Biopsy
- Breast Biopsy
- Others
By Technology
- CT-Scan
- Ultrasound-Guided Biopsy
- Stereotactic-Guided Biopsy
- MRI-Guided Biopsy
- Others
By Country
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- B. Braun Melsungen AG
- Medtronic
- FujifilmCorporation
- Danaher
- Hologic, Inc.
Asia Pacific Biopsy Devices Market Strategic Insights
Asia Pacific Biopsy Devices Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 440.80 Million |
| Market Size by 2027 | US$ 744.80 Million |
| CAGR (2019 - 2027) | 6.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
Asia Pacific Biopsy Devices Market Country and Regional Insights
